Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molidustat vs Darbepoetin Alfa in Dialysis Subjects with Renal Anemia
NCT03543657Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of molidustat in anemia of chronic kidney disease (2 arms), sponsored by Bayer. Primary endpoints: Mean Hemoglobin Level and Change in Mean Hemoglobin Level from Baseline. Started Jun 2018; status: completed.
02
Drugs
molidustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT03543657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03543657.